alphaveAPLLTD₹817.00

Alembic Pharmaceuticals Ltd.

₹ CrorePeersAJANTPHARM IPCALAB TORNTPHARM ALIVUS AKUMS AGARWALEYE ADVENZYMES AARTIPHARMMcap ₹16,058 Cr

View

In ₹ Crore except Per Share 12 Months Ending	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Non-current Assets
+ Property, Plant & Equipment	2,546.7	2,523.5	2,843.6	2,843.6
+ Capital Work-in-Progress	524.4	837.2	633.7	633.7
+ Other Intangibles	0.0	0.0	237.1	237.1
+ Intangibles under Development	0.0	0.0	49.7	49.7
+ Investments (Equity Method)	24.4	25.7	27.7	27.7
+ Non-current Investments	68.6	101.5	113.2	113.2
Non-current Financial Assets	68.6	101.5	113.2	113.2
+ Deferred Tax Assets	169.6	166.0	269.6	269.6
+ Other Non-current Assets	33.3	31.2	15.4	15.4
Total Non-current Assets	3,367.0	3,685.1	4,190.0	4,190.0
Current Assets
+ Inventories	1,643.5	2,288.1	2,510.6	2,510.6
+ Trade Receivables	1,024.8	1,399.8	1,466.3	1,466.3
+ Cash & Cash Equivalents	120.2	83.5	196.4	196.4
+ Other Bank Balances	6.4	6.6	6.3	6.3
+ Other Current Financial Assets	20.8	11.5	13.9	13.9
Current Financial Assets	1,172.2	1,501.4	1,682.9	1,682.9
+ Other Current Assets	221.8	287.2	338.4	338.4
Total Current Assets	3,078.6	4,087.8	4,542.6	4,542.6
Total Assets	6,445.6	7,772.9	8,762.6	8,762.6
Equity
+ Equity Share Capital	39.3	39.3	39.3	39.3
+ Other Equity / Reserves	4,778.9	5,151.6	5,635.5	5,635.5
Equity — Owners of Parent	4,818.2	5,190.9	5,674.8	5,674.8
+ Minority Interest	0.0	-1.4	-5.8	-5.8
Total Equity	4,818.2	5,189.5	5,669.0	5,669.0
Liabilities
+ Borrowings — Non-current	0.0	0.0	121.9	121.9
+ Other Non-current Financial Liab	62.9	46.8	44.8	44.8
Non-current Financial Liabilities	62.9	46.8	166.7	166.7
+ Provisions — Non-current	109.5	124.3	152.9	152.9
+ Other Non-current Liabilities	0.0	0.0	180.2	180.2
Non-current Liabilities	172.4	171.1	499.8	499.8
+ Borrowings — Current	430.5	1,195.6	1,238.9	1,238.9
+ Trade Payables	735.6	879.9	835.1	835.1
+ Other Current Financial Liab	163.7	165.3	302.9	302.9
Current Financial Liabilities	1,329.8	2,240.7	2,376.9	2,376.9
+ Provisions — Current	65.3	85.9	111.2	111.2
+ Current Tax Liabilities	0.0	18.9	35.0	35.0
+ Other Current Liabilities	60.0	66.8	70.8	70.8
Current Liabilities	1,455.0	2,412.3	2,593.8	2,593.8
Total Liabilities	1,627.4	2,583.4	3,093.6	3,093.6
Total Equity & Liabilities	6,445.6	7,772.9	8,762.6	8,762.6
Assets — additional as-filed lines
+ Non-current Assets Held for Sale	0.0	0.0	30.0	30.0
+ Current Tax Assets	41.0	11.0	10.7	10.7
Trade Payables — MSME split
+ Dues to Micro & Small — Current	—	60.3	59.8	59.8
+ Dues to Other Creditors — Current	—	819.6	775.3	775.3

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.